RhumbLine Advisers’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.17M | Buy |
|
|||||
|
2024
Q3 | $1.04M | Sell |
|
|||||
|
2024
Q2 | $676K | Buy |
|
|||||
|
2024
Q1 | $598K | Buy |
|
|||||
|
2023
Q4 | $561K | Sell |
|
|||||
|
2023
Q3 | $1.39M | Sell |
|
|||||
|
2023
Q2 | $2.06M | Sell |
|
|||||
|
2023
Q1 | $3.42M | Buy |
|
|||||
|
2022
Q4 | $2.37M | Buy |
|
|||||
|
2022
Q3 | $3.21M | Buy |
|
|||||
|
2022
Q2 | $2.47M | Buy |
|
|||||
|
2022
Q1 | $2.39M | Sell |
|
|||||
|
2021
Q4 | $4.17M | Buy |
|
|||||
|
2021
Q3 | $1.41M | Buy |
|
|||||
|
2021
Q2 | $1.62M | Sell |
|
|||||
|
2021
Q1 | $1.23M | Sell |
|
|||||
|
2020
Q4 | $811K | Buy |
|
|||||
|
2020
Q3 | $502K | Sell |
|
|||||
|
2020
Q2 | $494K | Buy |
|
|||||
|
2020
Q1 | $364K | Buy |
|
|||||
|
2019
Q4 | $545K | Buy |
|
|||||
|
2019
Q3 | $375K | Buy |
|
|||||
|
2019
Q2 | $395K | Buy |
|
|||||
|
2019
Q1 | $275K | Sell |
|
|||||
|
2018
Q4 | $274K | Buy |
|
|||||
|
2018
Q3 | $300K | Sell |
|
|||||
|
2018
Q2 | $174K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $73K | Buy |
|
|||||
|
2015
Q4 | $184K | Buy |
|
|||||
|
2015
Q3 | $141K | Buy |
|
|||||
|
2015
Q2 | $172K | Sell |
|
|||||
|
2015
Q1 | $191K | Buy |
|
|||||
|
2014
Q4 | $152K | Sell |
|
|||||
|
2014
Q3 | $160K | Buy |
|
|||||
|
2014
Q2 | $199K | Buy |
|
|||||
|
2014
Q1 | $163K | Sell |
|
|||||
|
2013
Q4 | $128K | Sell |
|
|||||
|
2013
Q3 | $133K | Buy |
|
|||||
|
2013
Q2 | $119K | Buy |
|